id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-N-0018-0001,FDA,FDA-2001-N-0018,"Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementation of the Common Technical Document; Notice of Public Meeting",Notice,General Notice,2001-12-31T05:00:00Z,2001,12,,,2025-02-10T16:52:56Z,01-32123,0,0,09000064804b5107
FDA-1978-N-0018-0441,FDA,FDA-1978-N-0018,Sunscreen Drug Products for Over-the-Counter Human Use; Final Monograph; Partial Stay; Final Rule,Notice,Notice of Stay of Action,2001-12-31T05:00:00Z,2001,12,2001-12-31T05:00:00Z,2002-04-02T04:59:59Z,2019-07-25T19:32:43Z,01-32086,0,0,090000648055a801
FDA-1993-D-0022-0001,FDA,FDA-1993-D-0022,FDA,Notice,NAD-Notice of Availability of Data,2001-12-31T05:00:00Z,2001,12,2001-12-27T05:00:00Z,,2008-05-16T23:23:01Z,,0,0,09000064804face9
FDA-2001-N-0015-0001,FDA,FDA-2001-N-0015,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Customer/Partner Service Surveys,Notice,30 Day Proposed Information Collection,2001-12-31T05:00:00Z,2001,12,2001-12-20T05:00:00Z,2002-01-23T04:59:59Z,2025-01-17T16:28:25Z,01-31335,0,0,09000064804b4d73
FDA-2001-D-0223-0001,FDA,FDA-2001-D-0223,FDA,Notice,N-Notice,2001-12-28T05:00:00Z,2001,12,2001-12-28T05:00:00Z,2002-03-21T04:59:59Z,2008-04-25T02:28:02Z,,0,0,09000064804e5374
FDA-2001-P-0155-0001,FDA,FDA-2001-P-0155,"FDA/DDM to Arnall, Golden Gregory",Other,ACK-Acknowledgement Letter,2001-12-27T05:00:00Z,2001,12,,,2008-04-25T02:27:48Z,,0,0,09000064804df043
FDA-2001-P-0053-0001,FDA,FDA-2001-P-0053,"Acknowledgment Letter from FDA DMB to Wilmer, Cutler & Pickering",Other,Acknowledgement Letter/Receipt,2001-12-27T05:00:00Z,2001,12,,,2024-09-23T22:37:14Z,,0,0,09000064804b7e38
FDA-2000-D-1403-0001,FDA,FDA-2000-D-1403,Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies,Notice,Guidance,2001-12-21T05:00:00Z,2001,12,2021-10-01T04:00:00Z,2002-12-12T04:59:59Z,2024-11-07T21:53:19Z,,1,0,09000064804f0f7f
FDA-2001-N-0172-0002,FDA,FDA-2001-N-0172,FDA,Notice,N-Notice,2001-12-17T05:00:00Z,2001,12,2001-12-17T05:00:00Z,2002-01-15T04:59:59Z,2008-04-25T02:27:22Z,,0,0,09000064804e0ae7
FDA-2001-P-0452-0001,FDA,FDA-2001-P-0452,Approval Letter from FDA CDER to AA1 International,Other,Approval,2001-12-17T05:00:00Z,2001,12,2021-01-28T05:00:00Z,,2021-02-01T17:19:08Z,,0,0,0900006484a0af87
FDA-2001-P-0191-0001,FDA,FDA-2001-P-0191,"FDA/DDM to Hogan & Hartson, LLP",Other,ACK-Acknowledgement Letter,2001-12-11T05:00:00Z,2001,12,,,2008-04-25T02:25:58Z,,0,0,09000064804e2665
FDA-2001-P-0215-0002,FDA,FDA-2001-P-0215,"Acknowledgment Letter from FDA DMB to Omega Laboratories, Ltd.",Other,ACK-Acknowledgement Letter,2001-12-07T05:00:00Z,2001,12,,,2024-08-23T13:49:30Z,,0,0,09000064804e488d
FDA-2001-N-0230-0002,FDA,FDA-2001-N-0230,FDA,Notice,NCR-Notice of Correction,2001-12-07T05:00:00Z,2001,12,,,2008-04-25T02:38:50Z,,0,0,09000064804e5d77
FDA-2001-D-0040-0001,FDA,FDA-2001-D-0040,FDA,Notice,NAD-Notice of Availability of Data,2001-11-29T05:00:00Z,2001,11,2001-11-29T05:00:00Z,2002-01-29T04:59:59Z,2008-04-25T01:57:07Z,,0,0,09000064804b6d71
FDA-2001-P-0086-0002,FDA,FDA-2001-P-0086,FDA/OC  to Washington Legal Foundation,Other,LET-Letter,2001-11-27T05:00:00Z,2001,11,,,2008-04-25T02:23:19Z,,0,0,09000064804b8543
FDA-2001-N-0070-0002,FDA,FDA-2001-N-0070,Agency Information Collection Activities; Submission for OMB Review; Comment Request; FDA Recall Regulations,Notice,30 Day Proposed Information Collection,2001-11-27T05:00:00Z,2001,11,2001-08-17T04:00:00Z,2001-09-18T03:59:59Z,2024-12-09T19:21:59Z,01-20842,0,0,09000064804b825f
FDA-2001-D-0032-0004,FDA,FDA-2001-D-0032,FDA,Notice,NEC-Notice of Extension,2001-11-21T05:00:00Z,2001,11,2001-11-21T05:00:00Z,2001-11-27T04:59:59Z,2008-04-25T01:57:06Z,,0,0,09000064804b6347
FDA-2001-D-0219-0002,FDA,FDA-2001-D-0219,Draft Guidance for Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees; Availability,Notice,NAD-Notice of Availability of Data,2001-11-20T05:00:00Z,2001,11,2001-11-19T05:00:00Z,2002-02-20T04:59:59Z,2010-05-10T16:34:55Z,,0,0,09000064804e4e02
FDA-1999-D-1301-0001,FDA,FDA-1999-D-1301,Guidance for Industry: Information Request & Discipline Review Letters Under the Prescription Drug User Fee Act,Notice,Guidance,2001-11-20T05:00:00Z,2001,11,2001-11-20T05:00:00Z,,2025-06-17T21:52:51Z,,1,0,09000064804da900
FDA-2001-N-0230-0001,FDA,FDA-2001-N-0230,FDA,Notice,NM-Notice of Meeting,2001-11-19T05:00:00Z,2001,11,2001-11-19T05:00:00Z,2002-01-26T04:59:59Z,2008-04-25T02:38:50Z,,0,0,09000064804e5c39
FDA-1978-N-0018-0440,FDA,FDA-1978-N-0018,"Memorandum of Meeting Between FDA/OCC and Cosmetic, Toiletry and Fragrance Association",Other,Memorandum,2001-11-19T05:00:00Z,2001,11,,,2019-08-07T12:11:46Z,,0,0,090000648055a7fe
FDA-1999-N-0053-0004,FDA,FDA-1999-N-0053,FDA,Notice,NFR-Notice of Final Rule,2001-11-16T05:00:00Z,2001,11,,,2008-04-25T00:00:45Z,,0,0,09000064804a6196
FDA-1999-N-0083-0001,FDA,FDA-1999-N-0083,FDA,Notice,NAD-Notice of Availability of Data,2001-11-15T05:00:00Z,2001,11,2001-11-15T05:00:00Z,2002-03-14T04:59:59Z,2008-04-25T00:00:59Z,,0,0,09000064804a6982
FDA-2000-D-0196-0001,FDA,FDA-2000-D-0196,Guidance for Industry: Fumonisin Levels in Human Foods and Animal Feeds; Availability,Notice,Notice of Availability,2001-11-14T05:00:00Z,2001,11,2001-11-09T05:00:00Z,2002-11-10T04:59:59Z,2018-10-10T18:41:38Z,,0,0,09000064804d4563
FDA-1980-N-0074-0075,FDA,FDA-1980-N-0074,FDA/ORA to Colgate-Palmolive Company,Other,PDN-Petition Denial,2001-11-14T05:00:00Z,2001,11,,,2008-05-30T22:52:47Z,,0,0,09000064805bb4db
FDA-2001-D-0137-0002,FDA,FDA-2001-D-0137,FDA,Notice,NAD-Notice of Availability of Data,2001-11-06T05:00:00Z,2001,11,2001-11-06T05:00:00Z,2002-02-05T04:59:59Z,2008-04-25T02:25:55Z,,0,0,09000064804ddb03
FDA-2001-D-0137-0007,FDA,FDA-2001-D-0137,FDA,Notice,NAD-Notice of Availability of Data,2001-11-06T05:00:00Z,2001,11,2001-11-06T05:00:00Z,2002-02-05T04:59:59Z,2008-04-25T02:25:55Z,,0,0,09000064804ddb0b
FDA-2001-N-0176-0001,FDA,FDA-2001-N-0176,FDA,Notice,N-Notice,2001-11-06T05:00:00Z,2001,11,,,2008-04-25T02:27:33Z,,0,0,09000064804e1102
FDA-2001-N-0176-0002,FDA,FDA-2001-N-0176,FDA,Notice,N-Notice,2001-11-06T05:00:00Z,2001,11,,,2008-04-25T02:27:34Z,,0,0,09000064804e133a
FDA-2001-D-0137-0001,FDA,FDA-2001-D-0137,FDA,Notice,NAD-Notice of Availability of Data,2001-11-06T05:00:00Z,2001,11,2001-11-06T05:00:00Z,2002-02-05T04:59:59Z,2008-04-25T02:25:55Z,,0,0,09000064804ddaef
FDA-2001-N-0074-0002,FDA,FDA-2001-N-0074,Schering Corp. et al.; Withdrawal of Approval of 51 New Drug Applications and 25 Abbreviated New Drug Applications; Correction,Notice,Correction,2001-11-06T05:00:00Z,2001,11,,,2025-01-29T14:22:16Z,01-27520,0,0,09000064804b831d
FDA-2001-D-0137-0006,FDA,FDA-2001-D-0137,FDA,Notice,NAD-Notice of Availability of Data,2001-11-06T05:00:00Z,2001,11,2001-11-06T05:00:00Z,2002-02-05T04:59:59Z,2008-04-25T02:25:55Z,,0,0,09000064804ddb0a
FDA-2001-D-0137-0009,FDA,FDA-2001-D-0137,FDA,Notice,NAD-Notice of Availability of Data,2001-11-06T05:00:00Z,2001,11,2001-11-06T05:00:00Z,2002-02-05T04:59:59Z,2008-04-25T02:25:55Z,,0,0,09000064804ddb0d
FDA-2001-D-0137-0008,FDA,FDA-2001-D-0137,FDA,Notice,NAD-Notice of Availability of Data,2001-11-06T05:00:00Z,2001,11,2001-11-06T05:00:00Z,2002-02-05T04:59:59Z,2008-04-25T02:25:55Z,,0,0,09000064804ddb0c
FDA-2001-N-0074-0003,FDA,FDA-2001-N-0074,Schering Corp. et al.; Withdrawal of Approval of 51 New Drug Applications and 25 Abbreviated New Drug Applications; Correction,Notice,Correction,2001-11-06T05:00:00Z,2001,11,,,2025-01-29T14:37:32Z,01-27520,0,0,09000064804b831e
FDA-2001-D-0137-0003,FDA,FDA-2001-D-0137,FDA,Notice,NAD-Notice of Availability of Data,2001-11-06T05:00:00Z,2001,11,2001-11-06T05:00:00Z,2002-02-05T04:59:59Z,2008-04-25T02:25:55Z,,0,0,09000064804ddb05
FDA-2001-D-0137-0005,FDA,FDA-2001-D-0137,FDA,Notice,NAD-Notice of Availability of Data,2001-11-06T05:00:00Z,2001,11,2001-11-06T05:00:00Z,2002-02-05T04:59:59Z,2008-04-25T02:25:55Z,,0,0,09000064804ddb09
FDA-2001-D-0137-0004,FDA,FDA-2001-D-0137,FDA,Notice,NAD-Notice of Availability of Data,2001-11-06T05:00:00Z,2001,11,2001-11-06T05:00:00Z,2002-02-05T04:59:59Z,2008-04-25T02:25:55Z,,0,0,09000064804ddb08
FDA-2001-D-0219-0001,FDA,FDA-2001-D-0219,Draft FDA Guidance on the Estabtishment and Operation of Clinical Trial Data Monitoring Committees; Public Meeting,Notice,NM-Notice of Meeting,2001-11-05T05:00:00Z,2001,11,,,2010-05-10T16:33:19Z,,0,0,09000064804e4d7b
FDA-2001-N-0016-0001,FDA,FDA-2001-N-0016,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Veterinary Adverse Drug Reaction, Lack of Effectiveness, Product Defect Report",Notice,30 Day Proposed Information Collection,2001-11-05T05:00:00Z,2001,11,2001-11-05T05:00:00Z,2001-12-06T04:59:59Z,2024-12-17T02:00:53Z,01-27641,0,0,09000064804b4ea8
FDA-2001-N-0171-0001,FDA,FDA-2001-N-0171,Agency Information Collection Activities; Announcement of OMB Approval; Third-Party Review Under FDAMA,Notice,Notice of Approval,2001-11-05T05:00:00Z,2001,11,,,2024-12-16T17:04:30Z,01-27642,0,0,09000064804e0921
FDA-2000-D-0027-0001,FDA,FDA-2000-D-0027,FDA,Notice,NAD-Notice of Availability of Data,2001-11-05T05:00:00Z,2001,11,,,2008-04-25T01:01:00Z,,0,0,09000064804aeaf2
FDA-2018-D-4115-0013,FDA,FDA-2018-D-4115,The Mammography Quality Standards Act Final Regulations: Preparing For MQSA Inspections; Final Guidance for Industry and FDA,Other,Guidance,2001-11-04T05:00:00Z,2001,11,2001-11-04T05:00:00Z,,2024-11-06T23:36:50Z,,1,0,0900006484644a3f
FDA-2001-P-0239-0005,FDA,FDA-2001-P-0239,"Letter from FDA CFSAN to Krislov & Associates, LTD.",Other,Letter(s),2001-10-31T05:00:00Z,2001,10,2020-07-06T04:00:00Z,,2024-09-09T17:22:16Z,,0,0,09000064804e6814
FDA-2001-P-0239-0004,FDA,FDA-2001-P-0239,Letter from FDA CFSAN to Center for Food Safety,Other,Letter(s),2001-10-31T05:00:00Z,2001,10,2020-07-06T04:00:00Z,,2024-09-09T17:22:06Z,,0,0,09000064804e6812
FDA-1998-N-0050-0002,FDA,FDA-1998-N-0050,Annual Comprehensive List of Guidance Documents at the Food and Drug Administration,Notice,General Notice,2001-10-29T05:00:00Z,2001,10,2001-10-24T04:00:00Z,,2015-04-11T02:07:31Z,,0,0,090000648056e813
FDA-2001-N-0174-0001,FDA,FDA-2001-N-0174,Electronic Interchange Standard for Digital ECG and Similar Data; Public Meeting,Notice,Meeting,2001-10-29T05:00:00Z,2001,10,,,2025-02-06T02:00:57Z,01-26821,0,0,09000064804e0d65
FDA-2001-N-0201-0001,FDA,FDA-2001-N-0201,Agency Information Collection Activities; Proposed Collection; Comment Request; Food Labeling; Notification Procedures for Statements on Dietary Supplements,Notice,60 Day Proposed Information Collection,2001-10-29T05:00:00Z,2001,10,,,2025-02-04T17:06:58Z,01-26885,0,0,09000064804e35f6
FDA-1999-F-0120-0003,FDA,FDA-1999-F-0120,Food Additives Permitted for Direct Addition to Food for Human Consumption; Change in Specifications for Gum or Wood Rosin Derivatives in Chewing Gum Base; Correction,Notice,Correction,2001-10-29T00:00:00Z,2001,10,,,2025-05-02T18:20:56Z,01-26708,0,0,09000064804ae961
FDA-2001-N-0199-0001,FDA,FDA-2001-N-0199,Agency Information Collection Activities; Announcement of OMB Approval; Premarket Notification 510(k) Submissions,Notice,Notice of Approval,2001-10-26T04:00:00Z,2001,10,,,2024-12-10T16:05:25Z,01-26573,0,0,09000064804e3357
FDA-2001-D-0094-0002,FDA,FDA-2001-D-0094,FDA,Notice,N-Notice,2001-10-23T04:00:00Z,2001,10,2001-10-23T04:00:00Z,2001-11-24T04:59:59Z,2008-04-25T02:23:58Z,,0,0,09000064804b90d5
FDA-2001-N-0104-0001,FDA,FDA-2001-N-0104,"Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry: Fast Track Drug Development Programs-Designation, Development, and Application Review",Notice,60 Day Proposed Information Collection,2001-10-23T04:00:00Z,2001,10,2001-10-23T04:00:00Z,2001-12-25T04:59:59Z,2025-02-03T20:03:20Z,01-26575,0,0,09000064804bae60
FDA-1980-N-0074-0074,FDA,FDA-1980-N-0074,FDA,Notice,N-Notice,2001-10-22T04:00:00Z,2001,10,2001-10-22T04:00:00Z,2002-01-15T04:59:59Z,2008-05-30T22:53:09Z,,0,0,09000064805bb4da
FDA-2001-N-0170-0001,FDA,FDA-2001-N-0170,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Medical Device Labeling Regulations,Notice,30 Day Proposed Information Collection,2001-10-19T04:00:00Z,2001,10,2001-10-16T04:00:00Z,2001-11-16T04:59:59Z,2024-12-19T19:57:40Z,01-25943,0,0,09000064804e07d0
FDA-2001-N-0566-0001,FDA,FDA-2001-N-0566,Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drugs for Investigational Use,Notice,60 Day Proposed Information Collection,2001-10-19T04:00:00Z,2001,10,2001-10-16T04:00:00Z,2001-12-18T04:59:59Z,2025-02-03T18:49:59Z,01-25918,0,0,090000648050b0cb
FDA-1998-D-0037-0001,FDA,FDA-1998-D-0037,FDA,Notice,NAD-Notice of Availability of Data,2001-10-12T04:00:00Z,2001,10,2001-10-12T04:00:00Z,2002-10-06T03:59:59Z,2008-05-16T21:18:13Z,,0,0,0900006480565bc6
FDA-2000-D-0100-0002,FDA,FDA-2000-D-0100,FDA,Notice,NAD-Notice of Availability of Data,2001-10-12T04:00:00Z,2001,10,2001-10-12T04:00:00Z,2002-10-06T03:59:59Z,2008-04-25T01:47:25Z,,0,0,09000064804c217b
FDA-2000-P-0102-0004,FDA,FDA-2000-P-0102,FDA,Notice,NEC-Notice of Extension,2001-10-12T04:00:00Z,2001,10,2001-10-12T04:00:00Z,2001-11-20T04:59:59Z,2008-04-25T01:47:38Z,,0,0,09000064804c22da
FDA-2000-P-0133-0004,FDA,FDA-2000-P-0133,FDA,Notice,NEC-Notice of Extension,2001-10-12T04:00:00Z,2001,10,2001-10-12T04:00:00Z,2001-11-20T04:59:59Z,2008-04-25T01:16:05Z,,0,0,09000064804cfd51
FDA-1998-D-0037-0002,FDA,FDA-1998-D-0037,FDA,Notice,NAD-Notice of Availability of Data,2001-10-12T04:00:00Z,2001,10,2001-10-12T04:00:00Z,2002-10-06T03:59:59Z,2008-05-16T21:18:13Z,,0,0,0900006480565c35
FDA-2001-N-0068-0001,FDA,FDA-2001-N-0068,Agency Information Collection Activities; Announcement of OMB Approval; Good Laboratory Practices (GLP) Regulations for Nonclinical Laboratory Studies,Notice,Notice of Approval,2001-10-12T04:00:00Z,2001,10,,,2025-02-11T16:56:25Z,01-25659,0,0,09000064804b81dc
FDA-2001-N-0226-0002,FDA,FDA-2001-N-0226,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Reports of Corrections and Removals,Notice,30 Day Proposed Information Collection,2001-10-12T04:00:00Z,2001,10,2001-10-12T04:00:00Z,2001-11-14T04:59:59Z,2025-01-15T20:59:09Z,01-25660,0,0,09000064804e57a8
FDA-2001-N-0072-0001,FDA,FDA-2001-N-0072,Agency Information Collection Activities; Announcement of OMB Approval; Current Good Manufacturing Practice Regulations for Type A Medicated Articles,Notice,Notice of Approval,2001-10-12T04:00:00Z,2001,10,,,2024-11-26T02:00:30Z,01-25658,0,0,09000064804b82d8
FDA-2001-N-0105-0001,FDA,FDA-2001-N-0105,Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Third-Party Premarket Submission Review and Quality System Inspections Under United States/European Community Mutual Recognition Agreement,Notice,60 Day Proposed Information Collection,2001-10-12T04:00:00Z,2001,10,2001-10-05T04:00:00Z,2001-12-05T04:59:59Z,2025-01-31T16:15:35Z,01-24998,0,0,09000064804bafb0
FDA-2000-D-0068-0001,FDA,FDA-2000-D-0068,FDA,Notice,NCR-Notice of Correction,2001-10-11T04:00:00Z,2001,10,,,2008-04-25T01:13:24Z,,0,0,09000064804afe17
FDA-2001-N-0202-0002,FDA,FDA-2001-N-0202,Workshop on Preclinical Testing for Endovascular Grafts,Notice,NM-Notice of Meeting,2001-10-10T04:00:00Z,2001,10,,,2009-01-07T16:52:55Z,,0,0,09000064804e3787
FDA-2001-N-0202-0001,FDA,FDA-2001-N-0202,Workshop on Preclinical Testing for Endovascular Grafts,Notice,NM-Notice of Meeting,2001-10-10T04:00:00Z,2001,10,,,2009-01-07T16:51:36Z,01–16471,0,0,09000064804e373f
FDA-2001-N-0567-0001,FDA,FDA-2001-N-0567,FDA,Notice,NH-Notice of Hearing,2001-10-10T04:00:00Z,2001,10,,,2008-04-25T02:39:30Z,,0,0,090000648050b0de
FDA-1999-P-0059-0004,FDA,FDA-1999-P-0059,FDA/DMB to Health Care Without Harm,Other,ACK-Acknowledgement Letter,2001-10-05T04:00:00Z,2001,10,,,2008-04-25T00:13:56Z,,0,0,09000064804a671c
FDA-2001-N-0047-0002,FDA,FDA-2001-N-0047,"Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting; Cancellation",Notice,General Notice,2001-10-02T04:00:00Z,2001,10,,,2025-01-30T19:01:03Z,01-24528,0,0,09000064804b78ae
FDA-1974-P-0001-0002,FDA,FDA-1974-P-0001,Notice of Proposed Rule-Making re Vinyl Chloride as an Ingredient of Drug and Cosmetic Aerosol Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2001-10-02T04:00:00Z,2001,10,,,2023-11-03T12:16:00Z,74-19657,0,0,090000648046a741
FDA-2001-P-0005-0001,FDA,FDA-2001-P-0005,Notice of Determination,Notice,N-Notice,2001-10-01T04:00:00Z,2001,10,,,2024-08-28T13:26:37Z,,0,0,09000064804b4014
FDA-2001-N-0173-0001,FDA,FDA-2001-N-0173,Agency Information Collection Activities; Proposed Collection; Comment Request; Rapid Response Surveys,Notice,60 Day Proposed Information Collection,2001-10-01T04:00:00Z,2001,10,2001-09-27T04:00:00Z,2001-11-27T04:59:59Z,2025-01-30T21:09:38Z,01-24163,0,0,09000064804e0bdd
FDA-1998-D-0037-0003,FDA,FDA-1998-D-0037,Content and Format for Geriatric Labeling,Notice,Guidance,2001-10-01T04:00:00Z,2001,10,2001-10-01T04:00:00Z,,2021-10-01T04:02:28Z,,0,0,0900006480565c32
FDA-1974-P-0001-0001,FDA,FDA-1974-P-0001,Notice of Proposed Rule-Making re: Vinyl Chloride as an Ingredient of Drug and Cosmetic Aerosol Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2001-10-01T04:00:00Z,2001,10,2001-10-01T04:00:00Z,1974-05-03T03:59:59Z,2023-11-03T12:14:27Z,74-9282,0,0,090000648046a6ff
FDA-2000-D-0002-0003,FDA,FDA-2000-D-0002,FDA,Notice,NAD-Notice of Availability of Data,2001-09-26T04:00:00Z,2001,9,,,2008-04-25T01:13:52Z,,0,0,09000064804ae5c1
FDA-2001-D-0164-0002,FDA,FDA-2001-D-0164,Guidance,Supporting & Related Material,GDL-Guidance,2001-09-26T04:00:00Z,2001,9,,,2008-04-25T02:27:39Z,,0,0,09000064804dff9e
FDA-2001-N-0172-0001,FDA,FDA-2001-N-0172,FDA,Notice,N-Notice,2001-09-26T04:00:00Z,2001,9,2001-09-26T04:00:00Z,2001-11-27T04:59:59Z,2008-04-25T02:27:22Z,,0,0,09000064804e0a96
FDA-2000-D-0002-0002,FDA,FDA-2000-D-0002,Guidance,Supporting & Related Material,GDL-Guidance,2001-09-26T04:00:00Z,2001,9,,,2008-04-25T01:13:52Z,,0,0,09000064804ae5c0
FDA-2001-D-0164-0001,FDA,FDA-2001-D-0164,FDA,Notice,NAD-Notice of Availability of Data,2001-09-26T04:00:00Z,2001,9,2001-09-26T04:00:00Z,2001-11-27T04:59:59Z,2008-04-25T02:27:39Z,,0,0,09000064804dff39
FDA-2001-N-0175-0001,FDA,FDA-2001-N-0175,Meeting on 11/14-15/01,Notice,NM-Notice of Meeting,2001-09-24T04:00:00Z,2001,9,2001-09-24T04:00:00Z,2001-12-18T04:59:59Z,2008-04-25T02:27:52Z,,0,0,09000064804e0ed7
FDA-2000-D-0031-0001,FDA,FDA-2000-D-0031,FDA,Notice,NAD-Notice of Availability of Data,2001-09-24T04:00:00Z,2001,9,2001-09-24T04:00:00Z,2001-12-25T04:59:59Z,2008-04-25T01:12:34Z,,0,0,09000064804aeb8d
FDA-2001-E-0151-0001,FDA,FDA-2001-E-0151,Determination of Regulatory Review Period for Purposes of Patent Extension; Trileptal,Notice,General Notice,2001-09-24T04:00:00Z,2001,9,2001-09-24T04:00:00Z,2001-11-24T04:59:59Z,2025-09-15T16:10:58Z,,0,0,09000064804ddd1d
FDA-2000-E-0239-0001,FDA,FDA-2000-E-0239,"Determination of Regulatory Review Period for Purposes of Patent
Extension; Synercid",Notice,General Notice,2001-09-21T04:00:00Z,2001,9,2001-09-21T04:00:00Z,2002-03-21T04:59:59Z,2025-07-09T16:09:54Z,,0,0,09000064804d59f6
FDA-2001-E-0210-0001,FDA,FDA-2001-E-0210,"Determination of Regulatory Review Period for Purposes of Patent
Extension; Kaletra",Notice,General Notice,2001-09-21T04:00:00Z,2001,9,2001-09-21T04:00:00Z,2002-03-21T04:59:59Z,2025-10-01T18:13:42Z,,0,0,09000064804e41c2
FDA-2001-F-0180-0001,FDA,FDA-2001-F-0180,Secondary Direct Food Additives Permitted in Food for Human Consumption,Notice,Notice of Final Rule,2001-09-21T04:00:00Z,2001,9,2001-09-21T04:00:00Z,2001-10-20T03:59:59Z,2025-11-06T20:46:42Z,,0,0,09000064804e1878
FDA-2001-E-0234-0001,FDA,FDA-2001-E-0234,"Determination of Regulatory Review Period for Purposes of Patent
Extension; Rescula",Notice,General Notice,2001-09-21T04:00:00Z,2001,9,2001-09-21T04:00:00Z,2002-03-21T04:59:59Z,2025-10-10T22:02:07Z,,0,0,09000064804e6296
FDA-1996-P-0041-0001,FDA,FDA-1996-P-0041,"Memorandum from FDA, Dave Read (HFD-7) to FDA Dockets Management Branch (HFA-305)",Other,Memorandum,2001-09-19T04:00:00Z,2001,9,,,2024-06-20T14:22:26Z,,0,0,09000064804fc5e9
FDA-1996-P-0025-0001,FDA,FDA-1996-P-0025,FDA,Notice,Notice of Availability,2001-09-18T04:00:00Z,2001,9,2001-09-18T04:00:00Z,2002-09-08T03:59:59Z,2016-05-31T16:17:22Z,,0,0,09000064804faaa3
FDA-1998-N-0087-0001,FDA,FDA-1998-N-0087,FDA,Notice,NAD-Notice of Availability of Data,2001-09-18T04:00:00Z,2001,9,2001-09-18T04:00:00Z,2002-09-08T03:59:59Z,2008-05-16T21:37:51Z,,0,0,0900006480585263
FDA-1994-P-0050-0002,FDA,FDA-1994-P-0050,FDA,Notice,NAD-Notice of Availability of Data,2001-09-18T04:00:00Z,2001,9,2001-09-18T04:00:00Z,2002-09-08T03:59:59Z,2008-05-16T23:21:35Z,,0,0,09000064804ffa38
FDA-1997-P-0017-0002,FDA,FDA-1997-P-0017,"Notice of Availability of Data re Small Entity Compliance Guide: “Food Labeling: Safe Handling Statements, Labeling of Shell Eggs; Refrigeration of Shell Eggs Held for Retail Distribution;” Availability",Notice,Notice of Data Availability,2001-09-18T04:00:00Z,2001,9,2001-09-18T04:00:00Z,2002-09-08T03:59:59Z,2015-05-12T15:29:10Z,,0,0,09000064805c9fc0
FDA-2001-E-0027-0001,FDA,FDA-2001-E-0027,FDA/CDER to the U. S. Patent & Trademark Office - Letter,Other,LET-Letter,2001-09-12T04:00:00Z,2001,9,,,2010-01-29T15:43:16Z,,0,0,09000064804b5c4f
FDA-2001-N-0047-0001,FDA,FDA-2001-N-0047,"Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting",Notice,Meeting,2001-09-12T04:00:00Z,2001,9,,,2025-01-30T17:36:45Z,01-22471,0,0,09000064804b78a3
FDA-2001-P-0216-0002,FDA,FDA-2001-P-0216,"FDA/CDER to Paul, Hastings, Janofsky & Walker LLP",Other,LET-Letter,2001-09-11T04:00:00Z,2001,9,,,2008-04-25T02:38:56Z,,0,0,09000064804e4a25
FDA-1999-P-0059-0003,FDA,FDA-1999-P-0059,FDA/CDRH to Sanford J. Lewis,Other,PDN-Petition Denial,2001-09-11T04:00:00Z,2001,9,,,2008-04-25T00:13:56Z,,0,0,09000064804a671a
FDA-2001-P-0001-0002,FDA,FDA-2001-P-0001,FDA/CDER to Mutual Pharmaceutical Company,Other,LET-Letter,2001-09-11T04:00:00Z,2001,9,,,2008-04-25T02:25:38Z,,0,0,09000064804b3acf
FDA-2001-N-0133-0002,FDA,FDA-2001-N-0133,Medical Devices; Exemption From Premarket Notification Requirements; Class I Devices,Notice,Correction,2001-09-10T04:00:00Z,2001,9,,,2025-02-11T15:27:21Z,01-22577,0,0,09000064804dda85
FDA-2001-D-0061-0001,FDA,FDA-2001-D-0061,FDA,Notice,NAD-Notice of Availability of Data,2001-09-07T04:00:00Z,2001,9,2001-09-07T04:00:00Z,2001-11-06T04:59:59Z,2008-04-25T01:57:12Z,,0,0,09000064804b80bb
FDA-2001-D-0161-0001,FDA,FDA-2001-D-0161,FDA,Notice,NAD-Notice of Availability of Data,2001-09-06T04:00:00Z,2001,9,2001-09-06T04:00:00Z,2001-12-06T04:59:59Z,2008-04-25T02:27:16Z,,0,0,09000064804dfb31